326
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Increased Systemic Immune-Inflammation Index Levels in Patients with Dry Eye Disease

, MD, , MD, , MD & , MD
Pages 588-592 | Received 10 Jul 2020, Accepted 07 Sep 2020, Published online: 29 Sep 2020

References

  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276–283. doi:10.1016/j.jtos.2017.05.008.
  • Bron AJ, dePaiva CS, Chauhan SK, et al. TFOS DEWS II Pathophysiology report. Ocul Surf. 2017;15:438–510. doi:10.1016/j.jtos.2017.05.011.
  • Rhee MK, Mah FS. Inflammation in dry eye disease: how do we break the cycle? Ophthalmology. 2017;124:14–19. doi:10.1016/j.ophtha.2017.08.029.
  • Massingale ML, Li X, Vallabhajosyula M, et al. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28:1023–1027. doi:10.1097/ICO.0b013e3181a16578.
  • Luo L, Li DQ, Doshi A, et al. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004;45:4293–4301. doi:10.1167/iovs.03-1145.
  • Qin B, Ma N, Tang Q, et al. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2016;26:372–376. doi:10.3109/14397595.2015.1091136.
  • Kaplan M, Ates I, Oztas E, et al. A new marker to determine prognosis of acute pancreatitis: PLR and NLR combination. J Med Biochem. 2018;37:21–30. doi:10.1515/jomb-2017-0039.
  • Kurtul BE, Ozer PA. Neutrophil-to-lymphocyte ratio in ocular diseases: a systemic review. Int J Ophthalmol. 2019;12:1951–1958. doi:10.18240/ijo.2019.12.18.
  • Sekeryapan B, Uzun F, Buyuktarakci S, et al. Neutrophil-to-lymphocyte ratio increases in patients with dry eye. Cornea. 2016;35:983–986. doi:10.1097/ICO.0000000000000872.
  • Celik T. Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with dry eye disease. Ocul Immunol Inflamm. 2018;26:1219–1222. doi:10.1080/09273948.2017.1340486.
  • Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcomes in patients with coronary artery disease. Eur J Clin Invest. 2020;50:e13230. doi:10.1111/eci.13230.
  • Fest J, Ruiter R, Mulder M, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer-A population-based cohort study. Int J Cancer. 2020;146:692–698. doi:10.1002/ijc.32303.
  • Jomrich G, Gruber ES, Winkler D, et al. Systemic immune-inflammation index (SII) predicts poor survival in pancreatic cancer patients undergoing resection. J Gastrointest Surg. 2020;24:610–618. doi:10.1007/s11605-019-04187-z.
  • Kim JW, Jung JY, Such CH, et al. Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still’s disease. Clin Rheumatol. 2020 Jul 4. doi:10.1007/s10067-020-05266-2.
  • Kim Y, Choi H, Jung SM, et al. Systemic immune-inflammation index could estimate the cross-sectional high activity and poor outcomes in immunosuppressive drug-naive patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton). 2019;24:711–717. doi:10.1111/nep.13491.
  • Tang B, Li S, Han J, et al. Associations between blood cell profiles and primary open-angle glaucoma: a retrospective case-control study. Ophthalmic Res. 2020;4:1–10.
  • Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118:615–621. doi:10.1001/archopht.118.5.615.
  • Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15:539–574. doi:10.1016/j.jtos.2017.05.001.
  • Whitcher JP, Shiboski CH, Shiboski SC, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s syndrome international registry. Am J Ophthalmol. 2010;49:405–415. doi:10.1016/j.ajo.2009.09.013.
  • Vitali C, Bombardieri S, Jonsson R, et al. European study group on classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–558. doi:10.1136/ard.61.6.554.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.